September - 2011
Showing Journal 2 of 14
Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial
Critical Care Medicine, 2011, 39(10):2263-2270
This prospective RCT of levosimendan vs placebo to prevent heart failure in 200 patients having valves reports a reduction in heart failure (15 vs 58%, p
However this needs to be taken with a grain of salt. Heart failure was defined as CI
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register
No Comments yet.